List of projects
All of your clinical data and biological samples will enable the realization of the research projects presented below.
BACAP
PACTOL
Ongoing
Social inequalities and the development and management of pancreatic cancer.
Ongoing
Analysis of the immune profile of resected pancreatic tumors.
Ongoing
Development of new experimental models for the advancement of innovative immunotherapy approaches in pancreatic cancer.
Ongoing
Development of a new technological approach for the detection of circulating biomarkers in patients with pancreatic cancer.
Ongoing
Identification of protective or risk factors for pancreatic cancer and development of a predictive score in high-risk patients (individuals with new-onset diabetes and/or chronic pancreatitis with a familial risk).
Ongoing
Epidemiological and clinico-biological profile of patients with pancreatic ductal adenocarcinoma.
Ongoing
Evaluation of pancreatic adenocarcinomas with isolated pulmonary metastases.
Ongoing
Pancreatic cancer in the elderly.
Ongoing
Early detection of pancreatic cancer by liquid biopsy.
Ongoing
Profile and outcome of long-term survivors of resected pancreatic cancer.
Ongoing
Pancreatic cancer registries in Europe.
Ongoing
Evaluation of the effectiveness of chemoradiotherapy in resectable pancreatic adenocarcinoma: retrospective multicenter study.
Completed
PREDICTCAN
Completed
Evaluation of the effectiveness of an in vitro vaccine formulation against pancreatic cancer.
Completed
PANAME
Completed
Evaluation of Gemcitabine, signature of response to chemotherapy.
Completed
Identification of a new target in pancreatic adenocarcinoma: pIgR, a new marker of tumor immunosuppressive history.
Completed
STMN1 as a biomarker for pancreatic cancer.
Completed
Pancreatic ductal adenocarcinoma requires tumor-intrinsic PI3Kδ activity to accelerate inflammatory microenvironment disease.
Completed
Study of venous thromboembolic disease in patients with pancreatic cancer.
Completed
Performance of a risk assessment model in predicting venous thromboembolism and early mortality in patients with pancreatic cancer.
Completed
Biomarkers of thrombosis in patients with pancreatic cancer.
Completed